sarsassoci
coronaviru
scov
protein
play
key
role
viral
assembl
bud
recent
studi
reveal
protein
could
interact
n
protein
golgi
complex
studi
show
scov
protein
coloc
golgi
apparatu
golgi
vector
marker
studi
protein
function
three
candid
small
interf
rna
sirna
correspond
gene
sequenc
design
transcrib
vitro
test
abil
silenc
protein
express
plasmid
pegfpm
encod
scov
protein
fusion
protein
egfp
use
silenc
report
gene
detect
hek
cell
transfect
sirna
construct
result
show
mean
green
fluoresc
intens
rna
transcript
significantli
reduc
express
glycoprotein
strongli
inhibit
cell
cotransfect
mspecif
sirna
find
demonstr
three
mspecif
sirna
abl
specif
effect
inhibit
glycoprotein
express
cultur
cell
block
accumul
mrna
provid
approach
studi
function
protein
develop
novel
prophylact
therapeut
agent
scov
infect
sever
acut
respiratori
syndromeassoci
coronaviru
scov
pathogen
agent
human
coronavirus
identifi
april
scov
group
four
coronaviru
envelop
singlestrand
positivesens
rna
genom
nucleotid
length
base
sequenc
complet
scov
genom
scov
encod
least
five
major
structur
protein
spike
envelop
e
membran
nucleocapsid
n
fouchier
et
al
rota
et
al
newli
identifi
shen
et
al
common
known
coronavirus
scov
caus
sever
acut
respiratori
distress
syndrom
diffus
alveolar
damag
dad
autopsi
kuiken
et
al
nichol
et
al
present
vaccin
specif
effect
antivir
method
avail
treat
diseas
effect
correspond
author
tel
fax
email
address
qizt
smmueducn
zt
qi
rna
interfer
rnai
cellular
process
doublestrand
rna
dsrna
molecul
silenc
target
gene
sequencespecif
cleavag
correspond
rna
transcript
transfect
small
interf
rna
sirna
mammalian
cell
lead
degrad
target
gene
mrna
arrest
protein
translat
silenc
protein
express
fire
et
al
elbashir
et
al
therefor
sirnamedi
rnai
may
provid
use
approach
studi
host
cellviru
interact
serv
possibl
therapeut
viru
infect
sirna
employ
therapeut
molecul
human
diseas
includ
cancer
neurogen
diseas
viral
infecti
diseas
shi
dy
kxhoorn
et
al
scov
rna
viru
may
also
ideal
target
studi
biolog
therapeut
rnai
method
date
number
publish
paper
show
sirnashrna
short
hairpin
rna
target
differ
region
gene
scov
genom
variou
sirnashrna
gener
strategi
rnaas
iii
specif
sirna
target
rna
depend
rna
polymeras
rdrp
n
gene
could
induc
specif
degrad
scov
mrna
human
cell
zhu
et
al
synthes
shrna
target
n
protein
tao
et
al
rdrp
lu
et
al
could
inhibit
express
target
protein
latter
significantli
reduc
plaqu
form
abil
scov
cell
sirna
target
e
n
protein
leader
sequenc
tr
utr
gene
qin
et
al
zhang
et
al
could
effect
inhibit
express
target
plasmidderiv
sirna
target
rdrp
meng
et
al
wang
et
al
leader
sequenc
bj
li
et
al
nonstructur
protein
could
specif
inhibit
express
target
protein
also
suppress
replic
propag
scov
cultur
vero
cell
line
ni
et
al
effect
sirnasshrna
probabl
result
global
reduct
subgenom
synthesi
subsequ
protein
express
scov
therefor
screen
valid
sirna
target
scov
genom
import
provid
inform
develop
better
scov
prophylaxi
therapi
among
five
scov
structur
gene
gene
encod
glycoprotein
amino
acid
length
contain
short
aminotermin
ectodomain
residu
three
transmembran
helic
residu
acid
carboxytermin
endodomain
voss
et
al
oostra
et
al
protein
abund
viral
membran
glycoprotein
key
protein
viral
assembl
bud
interact
n
protein
kuo
master
et
al
sinc
scov
protein
play
key
role
viral
life
cycl
experi
design
test
whether
specif
sirna
could
inhibit
express
protein
may
hold
promis
develop
scov
genespecif
therapeut
paper
subcellular
distribut
protein
establish
mammalian
cell
sirna
transcrib
vitro
introduc
cell
express
protein
result
show
protein
mainli
locat
golgi
apparatu
specif
sirna
correspond
scov
gene
specif
degrad
mrna
significantli
inhibit
protein
express
base
pair
fragment
scov
gene
synthes
accord
publish
sequenc
genbank
access
membran
protein
code
region
fragment
span
nt
nt
full
length
scov
genom
fragment
use
templat
amplifi
dna
fragment
encod
amino
acid
residu
scov
protein
polymeras
chain
reaction
pcr
forward
primer
revers
primer
underlin
sequenc
ecori
bamhi
site
respect
forward
revers
primer
final
concentr
primestar
tm
hs
dna
polymeras
final
concentr
ul
takara
use
pcr
condit
denatur
c
anneal
c
extens
c
cycl
ecoribamhi
fragment
insert
correspond
multiclon
site
eukaryot
express
vector
clonetech
result
plasmid
name
pegfpm
enhanc
green
fluoresc
protein
egfp
gene
locat
downstream
gene
ident
gene
publish
sequenc
confirm
dna
sequenc
bioasia
co
shanghai
plasmid
specif
locat
golgi
apparatu
mammalian
host
cell
kindli
provid
prof
yuwen
cong
depart
pathophysiolog
beij
institut
radiat
medicin
sirna
correspond
scov
membran
gene
design
accord
ambion
sirna
guidelin
scrambl
sirna
sequenc
wilson
et
al
egfp
sirna
use
neg
posit
control
silenc
respect
sequenc
sirna
blast
search
nation
center
biotechnolog
tabl
sequenc
templat
deoxynucleotid
sirna
use
target
gene
inform
ncbi
found
signific
homolog
gene
target
dna
templat
tabl
use
sirna
transcript
synthes
bioasia
co
oligonucleotidedirect
product
sirna
rna
polymeras
describ
previous
qin
et
al
transcript
reaction
oligonucleotid
templat
promot
primer
mix
denatur
heat
c
min
follow
ad
mixtur
klenow
reaction
buffer
dntp
mix
promega
usa
exoklenow
takara
dalian
nucleasefre
water
reaction
incub
c
min
vitro
transcript
perform
l
transcript
mix
l
hybrid
solut
l
reaction
buffer
l
rntp
mix
l
rna
polymeras
l
nucleasefre
water
incub
c
h
sens
antisens
rna
gener
separ
reaction
anneal
mix
transcript
reaction
incub
c
overnight
concentr
gener
dsrna
measur
absorb
nm
biophotomet
eppendorf
germani
nucleas
rnasefre
dnase
takara
ad
final
concentr
ug
sirna
respect
digest
ssrna
dsdna
sirna
assess
rna
gel
electrophoresi
agaros
one
volum
tesatur
ph
phenol
chloroform
isoamyl
alcohol
ad
vitro
transcrib
sirna
sampl
spun
rpm
microcentrifug
min
upper
aqueou
phase
collect
fresh
tube
mix
one
volum
chloroform
isoamyl
alcohol
centrifug
rpm
min
upper
aqueou
phase
mix
two
volum
ethanol
volum
mmoll
sodium
acet
ph
sampl
place
ice
min
follow
centrifug
rpm
min
pellet
wash
ml
ethanol
suspend
nucleasefre
water
use
puriti
integr
sirna
check
agaros
gel
electrophoresi
human
embryon
kidney
hek
cell
grown
c
dulbecco
modifi
eagl
medium
dmem
sigma
contain
heatinactiv
fetal
bovin
serum
gibco
brl
usa
supplement
lglutamin
mm
streptomycin
gml
penicillin
uml
twentyfour
hour
prior
transfect
cell
seed
plate
densiti
cell
per
well
fresh
medium
lwell
without
antibiot
transfect
adher
hek
cell
total
g
plasmid
dna
pegfpm
andor
nm
sirna
mix
lipofectamin
tm
invitrogen
ca
usa
use
accord
manufactur
instruct
cell
incub
c
variou
time
optim
gene
transcript
express
express
megfp
golgir
fusion
protein
observ
directli
invert
fluoresc
microscop
express
megfp
green
golgir
red
transfect
cell
examin
fluoresc
microscop
h
cotransfect
h
posttransfect
cell
glass
cover
slip
rins
phosophatebuff
salin
pb
fix
paraformaldehyd
min
c
examin
protein
confoc
microcroscopi
cell
wash
pb
three
time
store
pb
c
imag
view
collect
confoc
fluoresc
microscopi
leica
microsystem
heidelberg
gmbh
express
megfp
transfect
cell
examin
fluoresc
microscop
olympu
japan
h
transfect
flow
cytometr
analysi
megfp
express
cell
harvest
h
posttransfect
digest
trypsin
wash
twice
pb
resuspend
pb
measur
fluoresc
use
becton
dickinson
facscan
flow
cytomet
filter
emiss
nm
excit
nm
sampl
cell
count
analyz
cellquest
softwar
use
nontransfect
hek
cell
control
valu
calcul
percentag
cell
popul
exceed
fluoresc
intens
control
cell
mean
fluoresc
intens
popul
total
rna
test
control
cell
extract
h
posttransfect
use
rnaex
reagent
watson
shanghai
digest
rnasefre
dnase
takara
one
microgram
rna
revers
transcrib
cdna
oligo
dt
avian
myeloblastosi
viru
amv
revers
transcriptas
xl
takara
accord
manufactur
recommend
reaction
without
revers
transcriptas
perform
parallel
yield
pcr
product
primer
forward
primer
revers
primer
scov
gene
use
semiquantit
rtpcr
reaction
follow
denatur
c
anneal
c
extens
c
min
cycl
dehydrogenas
gapdh
use
intern
control
gapdh
primer
forward
primer
revers
primer
synthes
base
human
gapdh
mrna
sequenc
genbank
access
reaction
condit
follow
denatur
c
anneal
c
extens
c
cycl
realtim
quantit
pcr
lightcycl
roch
perform
describ
rajeevan
et
al
use
sybr
premix
ex
taq
tm
takara
briefli
reaction
carri
l
volum
contain
l
revers
transcript
product
quantit
scov
gene
transcript
level
cdna
hek
cell
transfect
pegfpm
dilut
rang
dilut
amplif
perform
use
primer
gapdh
gene
mrna
level
could
properli
normal
cdna
sampl
transfect
hek
cell
run
parallel
appropri
dilut
sampl
perform
analysi
rel
express
level
scov
gene
use
realtim
pcr
ct
method
use
livak
schmittgen
chang
scov
gene
express
sirna
cotransfect
cell
normal
gapdh
rel
express
mocktransfect
cell
calcul
sampl
primer
scov
gapdh
describ
cell
harvest
lyse
sd
equal
amount
total
protein
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
electrophoret
transfer
nitrocellulos
membran
follow
protocol
suggest
manufactur
biorad
ca
usa
block
nonspecif
bind
site
nonfat
milk
membran
incub
primari
antibodi
overnight
primari
antibodi
use
antigfp
mous
monoclon
antibodi
santacruz
dilut
antigapdh
mous
monoclon
antibodi
kangchen
shanghai
dilut
wash
blot
incub
alkalin
phosphataseconjug
goat
antimous
igg
immunoreact
band
visual
tetrazolium
bcipnbt
substrat
sinoamerican
shanghai
scov
gene
clone
ctermin
egfp
tag
could
use
monitor
protein
express
h
posttransfect
fluoresc
mainli
cytoplasm
hek
cell
condens
discret
loci
spot
fig
suggest
megfp
fusion
protein
locat
particular
cellular
compart
publish
data
show
protein
coronavirus
detect
golgi
complex
mammalian
cell
h
posttransfect
cell
analyz
confoc
microscopi
show
megfp
fusion
protein
coloc
golgi
apparatu
golgi
vector
fig
result
suggest
golgi
distribut
scov
protein
conform
also
consist
previou
studi
nal
et
al
silenc
express
scov
glycoprotein
use
rnai
technolog
specif
sirna
made
vitro
tran
scription
sens
antisens
sirna
templat
separ
transcrib
vitro
rna
polymeras
anneal
form
doublestrand
sirna
describ
section
overhang
leader
sequenc
gener
dsrna
dna
templat
digest
singlestrand
specif
nucleas
nucleas
rnasefre
dnase
respect
doubl
strand
sirna
nt
length
obtain
found
intact
fig
semiquantit
rtpcr
perform
examin
rna
level
scov
gene
sirna
cotransfect
cell
data
show
egfpsirna
reduc
accumul
mrna
fig
upper
panel
lane
compar
lane
control
sirna
scrambl
sequenc
effect
mrna
level
fig
upper
panel
lane
compar
lane
gapdh
mrna
affect
five
sirna
fig
bottom
panel
accur
quantifi
rna
level
scov
gene
realtim
quantit
pcr
perform
use
primer
specif
gene
gapdh
cdna
hek
cell
transfect
pegfpm
dilut
dilut
sampl
amplif
perform
use
primer
gapdh
gene
effici
target
refer
gene
similar
sampl
cdna
transfect
hek
cell
run
parallel
dilut
sampl
chang
scov
gene
express
sirna
cotransfect
cell
normal
gapdh
rel
gene
express
mocktransfect
cell
calcul
sampl
use
ct
method
result
show
scov
gene
mrna
level
decreas
cell
transfect
scov
respect
h
posttransfect
membran
gene
transcript
level
decreas
cell
transfect
egfpsirna
significantli
chang
cell
transfect
control
sirna
fig
determin
whether
sirna
could
effect
silenc
scov
glycoprotein
express
cultur
cell
pegfpm
variou
sirna
cotransfect
hek
cell
cell
examin
microscop
h
posttransfect
green
fluoresc
shown
fig
fluoresc
imag
much
stronger
hek
cell
transfect
control
sirna
compar
cell
transfect
scov
fig
upper
panel
faint
green
fluoresc
observ
egfpsirna
transfect
cell
upper
panel
b
fig
fluoresc
intens
hek
cell
cotransfect
control
sirna
show
signific
differ
pegfpm
transfect
cell
upper
panel
c
fig
bottom
panel
repres
correspond
imag
observ
light
microscopi
specif
silenc
green
fluoresc
confirm
least
three
independ
experi
examin
silenc
effect
scov
msirna
cell
collect
analyz
fluorescenceactiv
cell
sort
fac
h
transfect
sort
conduct
use
cellquest
softwar
select
cell
express
egfp
use
nontransfect
hek
cell
control
shown
fig
compar
cell
transfect
plasmid
pegfpm
alon
cell
cotransfect
pegfpm
control
sirna
gave
signific
reduct
egfp
express
wherea
egfpsirna
gave
reduct
percentag
fluoresc
cell
popul
mean
fluoresc
intens
respect
percentag
fluo
protein
express
better
consist
data
shown
fig
gapdh
affect
five
sirna
test
fig
bottom
panel
data
indic
sirna
silenc
scov
glycoprotein
express
block
accumul
mrna
individu
sar
usual
develop
high
fever
follow
sever
clinic
symptom
newli
emerg
diseas
safe
effect
vaccin
yet
avail
role
scov
protein
viral
life
cycl
especi
viral
assembl
bud
make
attract
target
antisar
drug
vaccin
research
rnai
induc
doublestrand
rna
molecul
silenc
target
gene
express
sinc
discoveri
caenorhabd
elegan
rnai
found
mani
organ
rnai
could
becom
reason
approach
experiment
therapeut
human
viral
pathogen
acut
chronic
infect
ketzinelgilad
et
al
consider
bodi
work
demonstr
rnai
great
prospect
viral
therapeut
applic
due
simplic
specif
compar
mani
antivir
strategi
recombin
megfp
protein
express
hek
cell
spotti
fluoresc
found
transfect
cell
condens
discret
loci
fig
use
confoc
microscopi
result
verifi
megfp
fusion
protein
predominantli
locat
golgi
compart
fig
consist
previou
studi
nal
et
al
howev
correct
protein
band
could
detect
western
blot
analysi
regular
cell
lysi
buffer
mm
triscl
ph
mm
nacl
sodium
azid
triton
gml
aprotinin
gml
pmsf
use
data
shown
specul
failur
detect
may
due
membranebind
properti
klumperman
et
al
therefor
altern
method
adopt
use
sd
lyse
cell
express
scov
protein
three
candid
mspecif
sirna
design
transcrib
vitro
inhibit
scov
protein
although
sirna
acquir
sever
method
donz
picard
miyagishi
taira
yang
et
al
svoboda
et
al
sui
et
al
loi
et
al
rubinson
et
al
transcript
vitro
polymeras
conveni
reliabl
approach
furthermor
applic
specif
design
sirna
nt
length
anim
model
recent
made
great
progress
includ
sirna
target
hepat
b
viru
xuan
et
al
japanes
enceph
viru
murakami
et
al
human
immunodefici
viru
ping
et
al
base
extens
screen
effect
sirna
vitro
proper
modif
adopt
improv
efficaci
durat
sirna
addit
vivo
use
exampl
endoribonucleaseprepar
sirna
effici
inhibit
hbv
replic
mous
model
xuan
et
al
might
better
therapeut
agent
fight
hbv
sirna
also
pursu
control
sar
de
clercq
potent
sirna
inhibitor
scov
vitro
evalu
efficaci
safeti
rhesu
macaqu
sar
model
use
clinic
viabl
deliveri
compar
three
dose
regimen
result
show
specif
sirna
could
mediat
antisar
effect
either
prophylact
therapeut
suggest
clinic
investig
warrant
work
underscor
prospect
sirna
enabl
signific
reduct
develop
time
new
target
therapeut
agent
bj
li
et
al
studi
rtpcr
realtim
quantit
pcr
western
blot
analys
show
could
decreas
scov
gene
transcript
translat
level
compar
sirna
control
fig
data
suggest
effect
gene
silenc
induc
sirna
sequenc
specif
entir
open
read
frame
orf
base
sirna
transcrib
vitro
effect
downregul
scov
rna
protein
level
correspond
report
mechan
sirna
degrad
target
mrna
result
three
scov
specif
sirna
studi
differ
activ
sirna
report
lab
et
al
suggest
effect
sirna
could
explor
efficaci
therapeut
agent
scov
infect
previou
studi
protein
reveal
interact
n
protein
et
al
work
pegfpm
cotransfect
full
length
scov
n
protein
hek
cell
fluoresc
recombin
megfp
strongli
enhanc
unpublish
result
futur
work
aim
investig
mechan
scov
n
protein
increas
express
protein
use
specif
sirna
